Castle Biosciences shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Castle Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Castle Biosciences held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Castle Biosciences by Ubs Global Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $704k | 32k | 22.15 |
2023-12-31 | $588k | 27k | 21.58 |
2023-09-30 | $460k | 27k | 16.89 |
2023-06-30 | $3.6M | 157k | 22.72 |
2023-03-31 | $3.6M | 157k | 22.72 |
2022-12-31 | $3.7M | 159k | 23.54 |
2022-09-30 | $3.8M | 146k | 26.08 |
2022-06-30 | $3.4M | 157k | 21.95 |
2022-03-31 | $8.0M | 178k | 44.86 |
2021-12-31 | $8.0M | 187k | 42.87 |
2021-09-30 | $12M | 179k | 66.50 |
2021-06-30 | $14M | 187k | 73.33 |
2021-03-31 | $13M | 194k | 68.46 |
2020-12-31 | $13M | 259k | 51.45 |
2020-09-30 | $13M | 259k | 51.45 |
2020-06-30 | $6.2M | 164k | 37.69 |
2020-03-31 | $4.6M | 156k | 29.81 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas